Advertise with us
Why SM?
Advertising rates
  Magazines
Gen.Mgmt.Review
Investor's Guide
Brand Equity
Corporate Dossier
   
 
  ET Headlines
  Stocks
  Forex
  World
 
A Strategic

Changing scenario in the pharmaceutical sector
by Dr R K Srivastava

History and Current Trends
The pharma industry is one of the most talked about industries around the world and India is no different. Even though the total size of the pharma industry is approximately equal to the turnover of Reliance Group, the industry has much hype around it - public controversies, government controls, and media coverage and more. The pharma sector has transformed a great deal over the past few decades. The top five companies, which were vibrant 20 years ago, are hardly so anymore. Glaxo, Sarabhai, Pfizer, and Hoechst, which were leaders, in 1980s are not even in the top five. Table I demonstrates this shift. One glance at this table makes it amply clear that the pharma sector, once the domain of multinational companies, is now being led by professionally managed Indian companies. The downfall of many erstwhile pharma leaders can be attributed to their rigid marketing practices. The quick analysis of Indian companies reveals that their progress is basically from the new products. Cipla and Sun Pharma are two companies that grew tremendously primarily due to their focus on new products. (See table II and III) However, recently the success rate of new products has also been on a decline because companies are more interested in introducing new products primairly to generate volume sales and therefore ignore brand building. In fact, with the passage of time, there has been steady deterioration of the success of new products. These days, the trend is to launch a new product, capture market share and if the response is good, then build the brand in subsequent years. This strategy has reaped dividends for companies like Ranbaxy, Cadila, Cipla, and Sun Pharmaceuticals. (See Table IV)

Doctors and Medical Representatives
A recent study conducted by the author reveals that more than 86 per cent of the doctors mentioned that the visit of medical representative is nothing but waste of time as they do not contribute much to the knowledge of doctors. This is a very serious shift. See Table V There is trend among the doctors to do super specialisation. This spurt in super specialisation has resulted in proliferation of many nursing homes and hospitals, which were of less importance in earlier days. Emergences of nursing homes and hospital have led to emergence of new market segments of hospital/nursing home consumer and has increased the importance of retail chemists attached to hospital, which can influence the prescription behavior of doctors. This had led many companies to take a re-look at the sales force deployment. In fact a few companies have already started hospital development in a big way. Many companies have have introduced multiple divisions to capture different customer segments.

Promotion Problems
The falling standards of medical representatives have led to development of external agencies (akin to the IT sector) to promote the products. The emergence of agency-led promotion, which is fairly common in the US, is becoming more and more popular in India with companies like Lupin and Pfizer making use of it. The once highly unionised and militant representatives have now mellowed down. But it is very difficult to get good talent for medical representatives as the youth have many more options today. This has been further complicated by doctors who do not give adequate time to medical representatives. (See Table VI) It is difficult for a medical rep to detail multiple products in about three to five minutes. Advertisements in pharma journals continue to be the last option. Samples, which were once a promotional too, have declined in importance (See Table VII). These days, many doctors prefer gifts instead of samples and top doctors expect better gifts than mere key chains, pens and so on. However, “customer focus” activities are emerging as an important tool in promoting the product. Take for instance events, which give direct access to the customer/doctor. As a result, the concept of symposiums, CRM activities, clinical meetings are becoming important

TO READ FURTHER... SUBSCRIBE TO YOUR COPY TODAY!!!

 

 
Copyright © Strategic Marketing All Rights Reservedd